期刊
TRANSLATIONAL RESEARCH
卷 169, 期 -, 页码 1-18出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2015.11.003
关键词
-
资金
- FIS (ISCIII) [PI12/00386, PI13/01450, PI15/00186]
- FEDER/FSE
- Miguel Servet program [CP 08/000689]
- Colombian Department For Science, Technology and Innovation (COLCIENCIAS) [568-2012]
Epigenetics is currently in an exponential phase of growth, constituting one of the most promising fields in science, particularly in cancer research. Impaired epigenetic processes can lead to abnormal gene activity or inactivity, causing cellular disorders that are closely associated with tumor initiation and progression. Thus, there is a pivotal role of massive sequencing techniques for epigenetics, which aim to find novel biomarkers, factors of prognosis and prediction, and targets for achieving personalized treatments. We present a brief description of the evolution of next generation sequencing technologies and its coupling with DNA methylation analysis techniques, highlighting its future in translational medicine and presenting significant findings in several malignancies. We also expose critical topics related to the implementation of these approaches, which is expected to be affordable for most research centers in the near future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据